- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CK10 Antibody KRT10/1948R recognizes cytokeratin 10, a type I intermediate filament protein encoded by the KRT10 gene on chromosome 17. Keratin 10 is predominantly expressed in differentiating keratinocytes of stratified squamous epithelia, particularly within the suprabasal layers of the epidermis. Its expression begins as keratinocytes withdraw from the cell cycle and transition from the proliferative basal compartment toward terminal differentiation. This characteristic distribution makes CK10 an established marker of epidermal maturation and a useful protein for investigating the organization and development of stratified epithelial tissues.
Keratin 10 forms intermediate filament networks with keratin 1, its principal type II keratin partner. These filament structures contribute to epidermal mechanical stability and help differentiating keratinocytes withstand physical stress. In normal skin, basal keratinocytes predominantly express keratins 5 and 14, while suprabasal differentiation is accompanied by increased expression of keratins 1 and 10. This coordinated change in keratin expression reflects the progressive maturation of epidermal cells. Researchers frequently examine CK10 alongside involucrin, loricrin, filaggrin, and other differentiation markers to evaluate epidermal development, barrier formation, and keratinocyte responses to environmental stimuli.
Altered KRT10 expression is associated with several dermatological conditions. In psoriasis and other hyperproliferative disorders, normal keratinocyte differentiation can be disrupted, resulting in changes in the distribution or abundance of suprabasal keratins. Pathogenic variants in KRT10 cause forms of epidermolytic ichthyosis, an inherited disorder characterized by epidermal fragility, blistering, and hyperkeratosis. Keratin 10 is also investigated in squamous epithelial tumors, where changes in its expression may reflect the degree of cellular differentiation. These associations make KRT10 relevant to research involving epidermal pathology, tissue repair, and epithelial tumor biology.
NSJ Bioreagents offers recombinant rabbit monoclonal clone KRT10/1948R for studying cytokeratin 10 expression in epithelial tissues. Recombinant monoclonal antibody production provides a defined antibody sequence and supports consistency between manufacturing batches. The Recombinant Cytokeratin 10 Antibody can be used to investigate the distribution of differentiated keratinocytes and changes in epidermal protein expression. A CK10 Antibody such as KRT10/1948R provides a useful tool for research into epidermal differentiation, keratin-associated disorders, and epithelial tissue organization.
Explore our Cytokeratin 10 Antibody KRT10/7804R, supported by Western blot and human skin immunohistochemistry data, for investigating epidermal differentiation and KRT10 expression.
Optimal dilution of the CK10 Antibody KRT10/1948R should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A cytoskeletal preparation extracted from human ectocervical epithelium was used as the immunogen for the CK10 Antibody KRT10/1948R.
Store the CK10 Antibody KRT10/1948R at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Cytokeratin 10 antibody, Keratin 10 antibody, KRT10 antibody, Type I Cytoskeletal Keratin 10 antibody, Cytokeratin-10 antibody, Keratin-10 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.